The inference from our work that Wnt signalling may have a pro-differentiation and tumour suppressive influence is supported by the recent identification of Wnt pathway mutations in neuroblastoma, which include probable loss of function mutations of LEF1 and VANGL1[20]. The gene discussed is LEF1; the disease is neuroblastoma.